Who We Are We are a second generation company that has been in business since Verizon recently engaged the agency to reimagine its shopping experience for next-gen customers. Keep Pernod Ricard as a long-time client—and keep the bar stocked. The campaign filled every one of the 3, seats. MAG also includes national tours, pop-up shops, product launches and drive-to-retail in its portfolio of capabilities, and was voted an Event Marketer Best Place to Work twice.
Cioffi holds the B. Detke is a psychiatrist with more than 20 years of research experience and extensive clinical and drug development expertise. This role included registration and regulatory commitment trials for Cymbalta, including major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia and chronic pain, as well as pediatric trials.
Detke teaches and supervises medical students and residents as Clinical Professor of Psychiatry at Indiana University School of Medicine. He trained in medicine and psychiatry at Harvard Medical School and at the Mt. Detke has published more than 60 manuscripts in peer-reviewed journals since Williams has more than 30 years of clinical research experience in both industry and academia.
She is now Professor Emerita at Columbia University. Williams is well known in the field for her development of psychiatric classifications and instruments to measure psychopathology. She is the author of more than scholarly publications and serves on the editorial boards of several psychiatric and social work journals.
She has received numerous awards for her achievements and contributions in social work and psychiatry. His research groups also led development programs for the analgesic drug tapentadol, the long-acting antipsychotic agent paliperidone palmitate, and other potential treatments for CNS disorders. Kobak is a psychologist with more than 30 years of clinical research experience in both industry and university medical settings.
Throughout his career, he has focused on clinical assessment, rater training, rating scale development and clinical trials methodology. Kobak founded the consultancy Research Training Associates, where he developed new methodologies for training and calibrating raters in clinical trials using digital technologies.
Kobak managed a clinical trials unit and pioneered the use of computer-administered rating scales in clinical trials. He authored computer-administered versions of several clinician-administered rating scales, including depression and anxiety scales that are widely used today, and a computer-administered version of the PRIME-MD, a diagnostic interview that was published in JAMA. Kobak received several NIMH grants to develop and study rater training methodology for depression, schizophrenia, and autism.
Negash serves as the scientific lead bridging research and operations to ensure MedAvante-ProPhase clinical trial services are implemented successfully from a scientific and service delivery perspective. Her work has focused on investigating factors associated with successful cognitive aging, including lifestyle factors such as cognitive activity, and on developing interventions that enhance cognitive fitness in older adults. She also studies successful cognitive aging in minority populations, particularly African-Americans.
Her other area of work focuses on examining implicit and explicit learning and memory systems in healthy aging and in mild cognitive impairment. Kane has been the principal investigator for research projects focusing on schizophrenia, psychobiolgy and treatment, recovery, and improving quality and cost of care.
He is the author of over peer-reviewed papers and serves on the editorial boards of numerous journals. Sue Vallow is a patient-reported outcomes PRO scientist with more than 20 years of experience developing and implementing patient-focused outcomes strategies and capabilities in numerous therapeutic areas with a specialty in CNS trials.
She is a co-author of more than 20 peer-reviewed papers and more than 70 research posters and presentations. Sofija Jovic is focused on the strategic combination of MedAvante-ProPhase as the thought leader in using measurement science and data quality to transform clinical trials.
Jovic guided the transformation from a four-person start-up to a global industry leader in collaboration with ProPhase founder Dr. Jovic started her career as a clinical psychologist: Jovic has published in peer-reviewed journals and presented scientific papers at professional and industry conferences. His academic research focuses on the etiology, phenomenology, and treatment of serious and persistent mental disorders. He has co-authored over 40 peer-reviewed publications and has contributed to multiple book chapters and review articles on schizophrenia and mental health research.
Lord-Bessen oversees MedAvante-ProPhase Clinical Data Analytics services including data management, statistics, and psychometric activities, including consultation on the development and validation of new Clinician-Reported and Patient-Reported Outcomes as well as the conversion of existing assessments to electronic format.
Lord-Bessen has over twenty years of experience in statistics and measurement. Twelve board members from leading universities and research institutions provide counsel and guidance to MedAvante-ProPhase on initiatives relating to mood, anxiety, schizophrenia, and other psychiatric disorders.
Co-chaired by John M. Richard Feinberg Chair in Schizophrenia Research. Eleven top leaders from major Japanese universities and research institutions provide their expertise to enhance the ability to collect high-quality research data with less error and greater signal detection.
At MedAvante-ProPhase, we look for colleagues who combine talent with a powerful desire to change healthcare for the better and ensure that effective therapies make it to the patients who need them. This is the mission uniting the clinicians, scientists, technologists, and operations experts whose mix of energy, inventiveness, and skill drives not only MedAvante-ProPhase but the entire WIRB-Copernicus Group family of companies in a relentless quest to improve clinical trials.
What do you do at MedAvante-ProPhase? As a member of the Business Development team, I am responsible for overseeing the creation of our responses to requests for information and proposals from drug development sponsors planning clinical trials. I also serve as a subject matter expert on clinical and technical aspects of our service solutions. Why did you decide to work at MedAvante-ProPhase? What do you like best about your job? MedAvante-ProPhase lacks the layers of hierarchy that can kill good ideas or contributions from different departments, and our entire team is determined to stay on the forefront of signal detection and clinical trial technology.
What are your colleagues like? Hard working, open and approachable. They like to be challenged, and they constantly push the limits of their comfort zone to ensure that quality of service is the first thing any customer remembers. What impact has working at MedAvante-ProPhase had on you? My job is to perform live clinical psychiatric interviews by phone and video conferencing with study subjects participating in clinical trials.
I also review documents and recordings of neuropsychological and psychiatric assessments conducted by other clinicians to provide feedback on scoring and administration.
I found in MedAvante-ProPhase a great place to use my behavioral health experience in a clinical trials setting, as well as a perfect fit for my years of face-to-face counseling, neuropsychological assessments, and phone work at an employee assistance program provider.
I like the excellent training, as well as the opportunity to work with a dedicated group of professionals. I have worked a number of places in my career before MedAvante-ProPhase but I never met a more caring and dedicated group of employees as I have here. While I work in the office, I feel just as connected to my peers who work remotely.
The learning at MedAvante-ProPhase for me started on day one, and has never stopped. As the company grows, so does my ability to gain further skills as a clinician and professional in different research areas.
I administer the adjudication process for large global studies by tracking cases, contacting sites for needed information, and assembling and storing the required documentation. I come from the medical field, having graduated as a Medical Doctor in Dominican Republic. I really love the flexibility that makes my work very convenient for me and my family.
I also like the way our multicultural team all treats each other with respect and I enjoy working with colleagues from around the world. In our department we are very diverse in culture, beliefs and opinions, but there is something common in all of us and that is the respect and the compassion we all have.
The FTC responded with a motion to dismiss the complaint for lack of subject-matter jurisdiction under Federal Rule of Civil Procedure 12 b 1 , and for failure to state a claim for which relief can be granted under Rule 12 b 6. The district court granted the FTC's motion to dismiss.
First, the court concluded that it lacked subject-matter jurisdiction because the press release was not "a 'final agency action'" under "section of the [Administrative Procedure Act]", 5 U. Second, the court held, "in the alternative, that Trudeau's claims failed to state a viable cause of action as a matter of law. Trudeau later filed an appeal which was unsuccessful in reversing the court's ruling. The temporary restraining order was replaced by a preliminary injunction.
However, Trudeau lost a motion to have the Board send a "corrective letter" to the television stations and subsequently dropped all claims for monetary damages. The case is still in litigation. The FTC filed a contempt of court action against Trudeau and the companies that market The Weight Loss Cure 'They' Don't Want You to Know About , alleging that Trudeau was in contempt of a court order by "deceptively claiming in his infomercials that the book being advertised establishes a weight-loss protocol that is 'easy' to follow.
When consumers buy the book, they find it describes a complex plan that requires intense dieting, daily injections of a prescribed drug that is not easily obtainable, and lifelong dietary restrictions. On November 19, , Trudeau was found in contempt of the court order for "patently false" claims in his weight loss book.
District Court Judge Robert W. Gettleman ruled that Trudeau "clearly misrepresents in his advertisements the difficulty of the diet described in his book, and by doing so, he has misled thousands of consumers. The court denied Trudeau's request to reconsider or stay this ruling on December 11 of the same year. On February 11, , Trudeau was arrested and appeared in U. District Court before Gettleman for criminal contempt of court after he "asked his supporters to email the federal judge overseeing a pending civil case brought against him by the Federal Trade Commission.
That is, no one can touch him," Barrett said. On November 28, , the U. Food and Drug Administration and the Federal Trade Commission issued warnings to companies selling human chorionic gonadotropin HCG as weight loss products as the claims are unsupported.
In February , the court-appointed receiver announced that a number of Trudeau's known assets, including a home in Ojai, California , would be auctioned, with proceeds to be applied toward unpaid fines and restitutions. Court officials informed GIN members that the club's business model "likely amounted to an illegal pyramid scheme", and that its relentlessly publicized group of 30 billionaire financial advisors known as the "GIN Council" did not exist.
GIN's remaining assets were later auctioned as well. In March , Trudeau was sentenced to 10 years in prison, an "unusually lengthy" term for a contempt conviction. In April , Guzman ordered that royalties payable to Trudeau from continuing sales of his books—now owned by a California company called Free is My Favorite LLC, which purchased the rights from Trudeau—be forwarded to a government-controlled trust and used for fine and restitution payments.
One common criticism by consumer groups is that Trudeau has had no medical training. Trudeau responds that by not having such training, he is not biased toward pharmaceutical companies and the FDA, and that medical doctors "are taught only how to write out prescriptions" for "poisons" and "cut out pieces of a person's anatomy. Trudeau has been criticized for his inability to provide evidence to back up his claims. Although he recites anecdotes, he has never provided evidence evaluated by licensed medical practitioners.
In instances where Trudeau has been asked to provide proof, he has misinterpreted medical studies or cited dubious or fictitious studies. For example, Trudeau cited a nonexistent year research study involving a natural cure for diabetes at the University of Calgary. In University of Calgary officials announced in a public statement that none of Trudeau's claims about the university's research were true, and that its attorneys had sent Trudeau a "cease and desist" letter, demanding that he stop associating himself with the school.
In August , the New York Consumer Protection Board warned consumers that Trudeau has used false claims of endorsements to promote his products, noting that the back cover of Natural Cures includes false endorsements.
Further, the NYCPB states that Trudeau's television advrtisements "give the false impression that Tammy Faye Messner opposes chemotherapy in favor of the 'natural cures' in Trudeau's book. The back cover includes the following quote from Dr.
Herbert Ley , a former commissioner of the U. Food and Drug Administration who died three years before the book was written: What the FDA is doing and what people think it's doing are as different as night and day. Bradford, says that this quote does not constitute a false endorsement of the book by Ley, but rather is merely a statement that is in line with the purpose of the book. From Wikipedia, the free encyclopedia.
This is the latest accepted revision , reviewed on 14 September Kevin Trudeau Trudeau in Retrieved 22 August State Bar of Wisconsin. Archived from the original on 5 December Retrieved 5 December Archived from the original on Retrieved September 19, TV pitchman Trudeau found guilty of criminal contempt".
Retrieved November 19, Archived from the original on March 16, Retrieved December 20, The Wall Street Journal via Cageyconsumer. Retrieved April 27, Natural scams "he" doesn't want you to know about ," Scientific American , March Calgary Herald Archived at the Wayback Machine..
Retrieved April 8, Retrieved 21 August A Sampler of Diet Scams and Abuse". A double-blind study" PDF. The American Journal of Clinical Nutrition. Your Wish is your Command [Informercial]. Archived from the original PDF on Interview With Kevin Trudeau". Archived from the original on September 27, Retrieved April 26, Also, with his proficient knowledge in Information Systems, he is responsible for solving IT issues when they arise. As System Project Specialist, he enjoys finding ways to fix problems and working with his fellow employees as these problems arise.
Within her first year at ABG Capital, Cherie has shifted towards a focus in Social Media where she is determined to provide any information others may find worthy of a like, retweet, or share. We value the oversight and expertise provided by our independent Board of Directors. They guide, govern, coach and hold us accountable to ensure the continued growth of our organization while protecting the interests of our stakeholders. As an organization, our "gems" are the various companies that we own.
We invest in our people, and their ideas to ultimately build a company from scratch or to further develop one already in existence. Our team has essentially built these successful organizations through their hard work, expertise and knowledge. These companies provide diversity which ensures the continued success of ABG Capital.
Their mission is to develop solutions through their Titanium III BackOffice that save their customers time and money through automation, consolidation and innovation.
GlobalPOPs is a wholesale dial-up carrier that frees service providers from the responsibility of managing a network. At GlobalPOPs we focus on the hard to reach markets. We build our networks in the areas where other providers are turning networks down. End User Services is a dial-up internet service provider with nationwide access.
With reliable and affordable connections, EUS is the clear choice for dial-up service. DTH Billing and Customer Management is a solution for one-time, recurring, and consumption-based billing requirements.
What We Do ABG Capital provides an environment where culture, expertise and resources are integrated to stimulate growth within our organization. Who We Are We are a second generation company that has been in business since Cultivate - encourage and support a healthy life balance Overcome - combine passion and perseverance to achieve success Respect - earn mutual trust and reliability Evolve - embrace the ability to adapt and innovate.
Dresses of the s Favorite Travel Destination: Australia Favorite type of Food: